Endured (9/4), Dutch Decoy (11/2), Starry Eyes (13/2), Diffident Spirit (13/2), Giuseppe Cassioli (9/1), Caribou (10/1), Lafan (10/1), Roman Dynasty (12/1 ...

Caribou Biosciences’ 2025 outlook aimed for key trial readouts for two cancer cell therapies in the first half of the year and the start of clinical testing in an autoimmune disease. The CRISPR ...

Shares of Caribou Biosciences (NASDAQ:CRBU) will be in focus on Friday after the gene-editing biotech announced plans to prioritize its lead oncology clinical programs, CB-010 and CB-011 ...

Caribou Biosciences is narrowing its pipeline and reducing its workforce by approximately 32% amid continued challenges in the cell and gene therapy sector. The company announced on 24 April it is ...

Caribou Biosciences is winnowing down for the second time in the last year, dropping a leukemia CAR-T asset and laying off 32% of staff to home in on two lead allogeneic cell therapy candidates.

You can reach Adam on Signal at stataf.54. Caribou Biosciences is delaying the readout of clinical trials involving its CRISPR T-cell therapies for blood cancer — hoping that longer follow-up ...

At the risk of stealing my Indiecast co-host’s bit, the question isn’t whether Caribou has passed the Five Albums Test. If it’s just a matter of making five great albums in a row ...

Caribou Coffee announced this week a major milestone in the company’s ongoing expansion, with the planned addition of up to eight new coffeehouses in Georgia. The new locations, which mark renewed ...

Young tree plantations like those behind these roaming caribou may be unsuitable habitat for decades following logging. Photo courtesy of Chris Johnson. The proposed road is called the Anahim ...

The study shows caribou herds changed their migratory duration, distance or elevation over 35 years of radio tag tracking. Decades of data following the migratory patterns of endangered caribou ...